StockData
Traws Pharma, Inc. logo

Traws Pharma, Inc. (TRAW) stock

TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$0.25−0.03 (-11.87%)

Close on Nov 13, 2026Market cap $3.86MP/E –Yield –

Traws Pharma statistics

57 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Q3 FY2026, expected soon
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$3.86M
$272.32M
Enterprise Value
-$1.16M
$146.23M

Share statisticsIndustry

Shares Change (YoY)
162.4%
10.8%
Shares Change (QoQ)
50.2%
0.50%
Float
10M
49M
Shares Held by Insiders
35.7%
11.7%
Shares Held by Institutions
40.1%
56.4%

Short sellingIndustry

Short Interest
683,674
–
Short Interest Change
-0.30%
-0.80%
Short % of Float
6.92%
9.01%
Short % of Shares Outstanding
4.45%
6.30%
Days to Cover
4.14
5.15

Stock price statisticsIndustry

52-Week High
$3.23
–
52-Week Low
$0.22
–
20-Day Moving Average
$0.30
–
50-Day Moving Average
$0.43
–
200-Day Moving Average
$1.06
–
Average True Range (14)
$0.04
–
Price Change (1 Week)
13.1%
-1.15%
Price Change (1 Month)
-37.7%
-4.87%
Price Change (3 Months)
-53.5%
-21.0%
Price Change (6 Months)
-86.6%
-20.6%
Price Change (YTD)
-77.8%
-23.6%
Price Change (1 Year)
-88.3%
-22.4%
Price Change (3 Years)
-98.5%
-29.5%
Price Change (5 Years)
-99.7%
-77.9%
Price Change (10 Years)
-100.0%
-65.4%
Average Volume (10 Days)
225,391
–
Average Volume (20 Days)
191,929
–
Average Volume (90 Days)
463,288
–
Relative Volume
1.16
0.70
Relative Strength Index (14)
35.1
43.4
Volatility (1 Year)
129.1%
80.1%
Beta (5 Years)
1.19
1.07

Returns on capitalIndustry

Return on Assets (ROA)
-159.2%
-40.6%
Return on Capital Employed (ROCE)
-1241.7%
-37.9%

Financial positionIndustry

Current Ratio
0.93
3.30
Quick Ratio
0.87
2.39

GrowthIndustry

Revenue Growth (3Y CAGR)
131.1%
2.25%
Revenue Growth (5Y CAGR)
64.6%
6.41%

EfficiencyIndustry

Profits Per Employee
-$3.08M
-$689.41K
Employee Count
7
74
WACC
11.0%
10.2%

Income statement (TTM)Industry

Operating Income
-$21.54M
-$21.37M
Net Income
-$21.57M
-$22.35M
EBITDA
-$21.40M
-$17.21M

Balance sheetIndustry

Net Cash (Debt)
$5.02M
$17.76M
Net Cash Per Share
$0.33
$0.80
Working Capital
-$712.00K
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$16.85M
-$12.38M

Dividends and yieldsIndustry

Earnings Yield
-559.1%
-21.8%
Buyback Yield
-109.4%
-0.76%
Shareholder Yield
-109.4%
0.00%

Scores and fair valueIndustry

Altman Z-Score
-85.39
0.23
Piotroski F-Score
4
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodTRAWS&P 500DifferenceTRAW per yearS&P 500 per year
1 month-38.8%-3.0%−35.8 pts
3 months-58.2%-2.8%−55.4 pts
Year to date-77.8%+11.5%−89.3 pts
1 year-85.8%+13.5%−99.3 pts
3 years-98.5%+77.7%−176.2 pts-75.1%+21.1%
5 years-99.7%+72.6%−172.3 pts-68.9%+11.5%
10 years-100.0%+308.2%−408.2 pts-66.8%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M TRAW shares were sold short on Oct 30, 2026, down 0.3% from the previous report, or 6.92% of the shares available to trade. At recent volumes it would take 4.1 days to buy them back. Over the last 20 sessions, 29.0% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026683,674-0.3%165,0694.1
Oct 15, 2026685,721-0.7%184,5503.7
Sep 30, 2026690,685+12.8%2,784,3331.0
Sep 15, 2026612,216-3.3%71,0758.6
Aug 31, 2026633,423+1.5%104,8066.0
Aug 14, 2026623,760-0.5%97,5526.4
Jul 31, 2026627,168-10.4%112,9155.5
Jul 15, 2026699,850-28.6%183,3083.8
Jun 30, 2026980,144-13.6%324,6083.0
Jun 15, 20261,134,900-17.5%700,2891.6
May 29, 20261,375,032-17.7%706,4891.9
May 15, 20261,671,345+198.4%10,790,9121.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?